Showing results (11-20 of 242) with videos related to
Sort By:
Pageof 25
Prostate Cancer and Prostatic Diseases|April 5, 2026
Practical management of hematuria after endoscopic surgery for benign prostatic obstructionAlexis E Te, Austen G Te, Ashwin Ramaswamy, et al.The Urologic Clinics of North America|November 29, 2011
Sexual function in men with metabolic syndromeRichard K Lee, Bilal Chughtai, Alexis E Te, et al.The Journal of Urology|October 19, 2010
Concordance of near infrared spectroscopy with pressure flow studies in men with lower urinary tract symptomsDoreen E Chung, Richard K Lee, Steven A Kaplan, et al.Urology|March 9, 2010
Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 gramsDoreen E Chung, Alexis E Te, David R Staskin, et al.Urology|September 30, 2019
Ejaculatory Preserving Middle Lobe Onl-Transurethral Resection and Vaporization of the Prostate: 12-Year ExperienceZeynep Gul, Bilal Chughtai, Alexis E Te, et al.BJU International|January 17, 2012
Central obesity as measured by waist circumference is predictive of severity of lower urinary tract symptomsRichard K Lee, Doreen Chung, Bilal Chughtai, et al.World Journal of Urology|June 30, 2020
An evaluation of the federal adverse events reporting system data on adverse effects of 5-alpha reductase inhibitorsMatthew B Harrell, Kaylee Ho, Alexis E Te, et al.International Braz J Urol : Official Journal of the Brazilian Society of Urology|March 16, 2013
Noninvasive methods to evaluate bladder obstruction in menDean S Elterman, Bilal Chughtai, Richard Lee, et al.Therapeutic Advances in Urology|October 2, 2012
Experience with the combination of dutasteride and tamsulosin in the long-term management of benign prostatic hyperplasiaBilal Chughtai, Dean S Elterman, Richard Lee, et al.Reviews in Urology|March 26, 2013
Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic HyperplasiaDean S Elterman, Bilal Chughtai, Richard K Lee, et al.Pageof 25